Effectiveness against both herpes zoster and postherpetic neuralgia remained stable for at least 4 years after vaccination.

In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.

Mr. Matthew Adams Ayamba, Adaklu District Health Director, has called on the people of Adaklu to take personal hygiene seriously.He stated that “with the reported resurgence of COVID-19 and the ...

AIDS Healthcare Foundation ( AHF ), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Pandemic Prevention, Preparedness, and Response After the Agreement: ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

NanoViricides, Inc. is a publicly traded clinical-stage company focused on creating special purpose nanomaterials for antiviral therapy. The company's innovative nanoviricide class of drug candidates ...

The Africa Centre for Disease Control and Prevention (Africa CDC) says Democratic Republic of Congo (DRC), Sierra Leone, and Uganda account for over 84 per cent of Mpox cases across Africa.

Thailand reports 40 mpox cases in 2023; sexual transmission is the main cause. Vigilant monitoring and advice on safe practices continue.